Showing results (31-40 of 5,284) with videos related to
Sort By:
Pageof 529
Science (New York, N.Y.)|July 23, 1982
Evidence for the clonal origin of spontaneous metastasesJ E Talmadge, S R Wolman, I J FidlerCancer Research|January 1, 1983
Comparative studies on the quantitative analysis of experimental metastatic capacityI R Hart, J E Talmadge, I J FidlerComputers and Biomedical Research, an International Journal|February 1, 1987
An interactive computer program for the analysis of growth curvesS Guo, R Simon, J E Talmadge, et al.Cancer Immunology, Immunotherapy : CII|January 1, 1989
Chemoimmunotherapy with cyclophosphamide and bestatin in experimental metastasis in miceF Abe, M Schneider, P L Black, et al.Experimental Hematology|February 1, 1996
Activity of acetyl-n-ser-asp-lys-pro (AcSDKP) on hematopoietic progenitor cells in short-term and long-term murine bone marrow culturesJ D Jackson, Y Yan, C Ewel, et al.Circulatory Shock|January 1, 1989
Protective effect of SK&F 86002, a novel dual inhibitor of arachidonic acid metabolism, in murine models of endotoxin shock: inhibition of tumor necrosis factor as a possible mechanism of actionA M Badger, D Olivera, J E Talmadge, et al.Cancer Research|September 1, 1984
Development of biological diversity and susceptibility to chemotherapy in murine cancer metastasesJ E Talmadge, K Benedict, J Madsen, et al.Journal of Bacteriology|August 1, 1975
Specificity and genetics of S-adenosylmethionine transport in Saccharomyces cerevisiaeT F Petrotta-Simpson, J E Talmadge, K D SpenceInternational Journal of Immunopharmacology|August 24, 1999
Impaired T and NK cell response of bone marrow and peripheral blood stem cell products to interleukin (IL)-2I Ozerol, A Ageitos, D G Heimann, et al.Cancer Research|November 1, 1987
Systematic preclinical study on the therapeutic properties of recombinant human interleukin 2 for the treatment of metastatic diseaseJ E Talmadge, H Phillips, J Schindler, et al.Pageof 529